Inventor · disambiguated record
Hong Liu
Also filed as: HOLDERMAN SUSAN D · LIU HONG · LIU HONG Y · LIU HONG YAN
120 granted patents·59 pending applications·1,243 citations·filing 2001–2025
99Inventor score
Files withEUREKA THERAPEUTICS INC28MERCK SHARP & DOHME18ZYMOGENETICS INC17BRISTOL MYERS SQUIBB PHARMA CO16IRM LLC15
Top patents by PatentIndex Score
179 records- 0198US7468423B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS INC·Filed 2006·Granted Dec 23, 2008·29 cites·14 claims
- 0298US7157559B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS INC·Filed 2004·Granted Jan 2, 2007·108 cites·14 claims
- 0397US7595174B2Polynucleotide encoding an il-29 polypeptideZYMOGENETICS LLC·Filed 2006·Granted Sep 29, 2009·33 cites·8 claims
- 0497US7588918B2Polynucleotide encoding an IL-29 polypeptideZYMOGENETICS LLC·Filed 2006·Granted Sep 15, 2009·27 cites·8 claims
- 0597US7588919B2Polynucleotide encoding an IL-28B polypeptideZYMOGENETICS LLC·Filed 2006·Granted Sep 15, 2009·26 cites·8 claims
- 0697US7582450B2Polynucleotide encoding an IL-29 polypeptideZYMOGENETICS LLC·Filed 2006·Granted Sep 1, 2009·25 cites·8 claims
- 0797US7517961B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS LLC·Filed 2006·Granted Apr 14, 2009·29 cites·14 claims
- 0897US7514536B2Homogeneous preparations of IL-28A cysteine mutantsZYMOGENETICS INC·Filed 2006·Granted Apr 7, 2009·29 cites·14 claims
- 0997US7495078B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS INC·Filed 2006·Granted Feb 24, 2009·31 cites·14 claims
- 1097US7495077B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS INC·Filed 2006·Granted Feb 24, 2009·28 cites·14 claims
- 1197US7495079B2Homogeneous preparations of IL-28 AZYMOGENETICS INC·Filed 2006·Granted Feb 24, 2009·29 cites·14 claims
- 1297US7485701B2Homogeneous preparations of IL-28 and IL-29ZYMOGENETICS INC·Filed 2006·Granted Feb 3, 2009·29 cites·14 claims
- 1397US7485702B2Homogeneous preparations of IL-28A cysteine mutantsZYMOGENETICS INC·Filed 2006·Granted Feb 3, 2009·30 cites·14 claims
- 1497US7479542B2Homogeneous preparations of IL-28A mutantsZYMOGENETICS INC·Filed 2006·Granted Jan 20, 2009·29 cites·14 claims
- 1596US7727518B2Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis BZYMOGENETICS LLC·Filed 2008·Granted Jun 1, 2010·22 cites·15 claims
- 1696US7662589B2Polynucleotide encoding an IL-28A polypeptideZYMOGENETICS LLC·Filed 2006·Granted Feb 16, 2010·21 cites·8 claims
- 1796US7662590B2Polynucleotide encoding an IL-28A polypeptideZYMOGENETICS LLC·Filed 2006·Granted Feb 16, 2010·21 cites·8 claims
- 1896US7638305B2Polynucleotide encoding an IL-28A polypeptideZYMOGENETICS LLC·Filed 2006·Granted Dec 29, 2009·21 cites·8 claims
- 1996US7629149B2Polynucleotide encoding an IL-28A polypepideZYMOGENETICS LLC·Filed 2006·Granted Dec 8, 2009·21 cites·8 claims
- 2096US7629148B2Polynucleotide encoding an IL-28B polypeptideZYMOGENETICS LLC·Filed 2006·Granted Dec 8, 2009·20 cites·8 claims
- 2196US7608428B2Polynucleotide encoding an IL-28B polypeptideZYMOGENETICS LLC·Filed 2006·Granted Oct 27, 2009·24 cites·8 claims
- 2296US7608427B2Polynucleotide encoding an IL-28B polypeptideZYMOGENETICS LLC·Filed 2006·Granted Oct 27, 2009·24 cites·8 claims
- 2396US7544779B2Homogeneous preparations of IL-28ZYMOGENETICS LLC·Filed 2006·Granted Jun 9, 2009·23 cites·14 claims
- 2495US11155615B2Anti-ROR1 antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Oct 26, 2021·13 cites·13 claims
- 2595US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 2695US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 2795US7342008B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Mar 11, 2008·15 cites·30 claims
- 2894US10766919B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Sep 8, 2020·9 cites·15 claims
- 2994US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 3094US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 3194US7423033B2Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted Sep 9, 2008·13 cites·32 claims
- 3293US7498324B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Mar 3, 2009·18 cites·39 claims
- 3392US10822413B2Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·13 cites·27 claims
- 3492US10011658B2Constructs targeting AFP peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·14 cites·24 claims
- 3592US8722691B2Azolopyrimidines as inhibitors of cannabinoid 1 activityHE XIAOHUI·Filed 2007·Granted May 13, 2014·32 cites·9 claims
- 3692US7390802B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jun 24, 2008·17 cites·36 claims
- 3791US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 3891US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 3991US7655647B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Granted Feb 2, 2010·13 cites·8 claims
- 4090US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 4189US7250274B2IL-21 production in prokaryotic hostsZYMOGENETICS INC·Filed 2003·Granted Jul 31, 2007·24 cites·7 claims
- 4289US6632812B2Substituted lactams as inhibitors of Aβ protein productionDU PONT PHARM CO·Filed 2001·Granted Oct 14, 2003·25 cites·27 claims
- 4388US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 4488US11384144B2T cell receptor-like antibodies specific for a PRAME peptideMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 12, 2022·3 cites·46 claims
- 4588US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 4687US8431607B2Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2007·Granted Apr 30, 2013·12 cites·8 claims
- 4787US7112583B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Sep 26, 2006·13 cites·39 claims
- 4887US6960576B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 1, 2005·13 cites·54 claims
- 4987US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 5087US6503902B2Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 7, 2003·21 cites·47 claims
Showing the top 50 of 179 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →